Invention Grant
US08778963B2 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
有权
羟胺和肟取代的咪唑并喹啉，咪唑并吡啶和咪唑并吡啶类
- Patent Title: Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
- Patent Title (中): 羟胺和肟取代的咪唑并喹啉，咪唑并吡啶和咪唑并吡啶类
-
Application No.: US10595895Application Date: 2004-11-24
-
Publication No.: US08778963B2Publication Date: 2014-07-15
- Inventor: Larry R. Krepski , Joseph F. Dellaria, Jr. , Gregory J. Marszalek
- Applicant: Larry R. Krepski , Joseph F. Dellaria, Jr. , Gregory J. Marszalek
- Applicant Address: US MN St. Paul
- Assignee: 3M Innovative Properties Company
- Current Assignee: 3M Innovative Properties Company
- Current Assignee Address: US MN St. Paul
- International Application: PCT/US2004/039673 WO 20041124
- International Announcement: WO2005/051324 WO 20050609
- Main IPC: C07D487/06
- IPC: C07D487/06 ; C07D471/06 ; A61K31/437
Abstract:
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Public/Granted literature
- US20070099901A1 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines Public/Granted day:2007-05-03
Information query
